Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
06/25/2008 | EP1935417A1 Composition for use in prevention of hypoglycemic condition |
06/25/2008 | EP1935414A2 Carbonic anhydrase activators for enhancig learning and memory |
06/25/2008 | EP1933858A1 A medical composition for treating wounds |
06/25/2008 | EP1933831A2 Modulators of atp-binding cassette transporters |
06/25/2008 | EP1933821A1 Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
06/25/2008 | EP1675850B1 Quinoline compounds and their uses |
06/25/2008 | EP1492534B1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
06/25/2008 | EP1485345B1 Urokinase inhibitors, production and use thereof |
06/25/2008 | EP1458393B1 Substituted diketopiperazines as oxytocin antagonists |
06/25/2008 | EP1395604B1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
06/25/2008 | EP1328271B1 Treatment of neurological and neuropsychological disorders |
06/25/2008 | EP1261320B1 Micellar pharmaceutical compositions for buccal and pulmonary application |
06/25/2008 | EP1200127B1 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
06/25/2008 | EP1173180B1 Camptothecin analogs and methods of preparation thereof |
06/25/2008 | EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
06/25/2008 | EP1041991B1 Non antibacterial tetracyclins for the treatment of multiple sclerosis |
06/25/2008 | EP0988051B1 Lyme combination compositions and uses |
06/25/2008 | EP0986382B1 Raf kinase inhibitors |
06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
06/25/2008 | CN101205251A Chinese south China sea signal taro snail nerve toxin gene Lt3.2 and uses thereof |
06/25/2008 | CN101204560A Pharmaceutical capsules for sunstroke |
06/25/2008 | CN101204556A Ointment for hypothyroid cystic hyperplasia and preparing method thereof |
06/25/2008 | CN101204537A Chinese traditional medicine composite for reducing spitting, dispelling wind, and relieving convulsion and preparation method thereof |
06/25/2008 | CN101204415A Patch for treating sunstroke |
06/25/2008 | CN101204202A Ruminant humus pellet feed |
06/25/2008 | CN100397081C Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy |
06/25/2008 | CN100396769C Novel probiotics for pet food applications |
06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
06/25/2008 | CN100396676C Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
06/25/2008 | CN100396675C Prodrugs of proton pump inhibitors |
06/25/2008 | CN100396669C Production of pyriphenanthrenone as anti-fibrosis medicine |
06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
06/25/2008 | CN100396327C Use of composition in preparing antifatigue medicament |
06/25/2008 | CN100396283C Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
06/24/2008 | US7392233 Image searching system, image searching method, and a recording medium storing an image searching program |
06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
06/24/2008 | US7390905 Tachykinin receptor antagonists for use treating e.g. emesis, depression, urinary disorder |
06/24/2008 | US7390898 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
06/24/2008 | US7390896 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
06/24/2008 | US7390890 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
06/24/2008 | US7390822 Delta-2 opioid receptor agonists; protecting cardiac and cerebral organs |
06/24/2008 | US7390821 Administering nicotinic acetylcholine receptor antagonist; ocular diseases; monoclonal antibodies |
06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
06/24/2008 | US7390808 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes |
06/24/2008 | US7390805 Tyrosine kinase inhibitors; antiproliferative agents; antitumor agents |
06/24/2008 | US7390802 Substituted lactams as inhibitors of Aβ protein production |
06/24/2008 | US7390797 Fused indazole compounds |
06/24/2008 | US7390785 Amino acid sequences; from venom of snails; analgesics |
06/24/2008 | US7390668 Halogenated xanthan compound |
06/24/2008 | US7390625 Apoptosis-associated protein and use thereof |
06/19/2008 | WO2008073961A2 Compounds and methods for modulating the silencing of a polynucleotide of interest |
06/19/2008 | WO2008073774A1 Systems and methods for detecting infrared emitting composites and medical applications therefor |
06/19/2008 | WO2008073331A2 Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue |
06/19/2008 | WO2008073257A1 Use of prodrugs of gaba analogs for treating diseases |
06/19/2008 | WO2008072778A1 Therapeutic agent for urinary tract disease |
06/19/2008 | WO2008072726A1 1-phenyl 1-thio-d-glucitol derivative |
06/19/2008 | WO2008072723A1 ANTI-Claudin-3 MONOCLONAL ANTIBODY, AND TREATMENT AND DIAGNOSIS OF CANCER USING THE SAME |
06/19/2008 | WO2008072703A1 Biphenylamide derivative |
06/19/2008 | WO2008072682A1 Imidazo[1,2-b]pyridazine derivative |
06/19/2008 | WO2008072663A1 Composition for amelioration/prevention of adverse side effect in steroid therapy |
06/19/2008 | WO2008072658A1 2-phenylnicotinic acid derivative |
06/19/2008 | WO2008072655A1 Imidazothiazole derivatives |
06/19/2008 | WO2008072634A1 Fused heterocyclic compound |
06/19/2008 | WO2008072591A1 Iron metabolism-improving agent |
06/19/2008 | WO2008072360A1 Catechin composition and method for producing the same |
06/19/2008 | WO2008071934A1 Treatment of cachexia |
06/19/2008 | WO2008071173A1 Preparations for inhibiting prostaglandin e2 synthesis |
06/19/2008 | WO2008071075A1 A process for preparation of extract of broussonetia papyritera and the use thereof in manufacture of a medicament |
06/19/2008 | US20080147131 Method for muscle delivery of drugs, nucleic acids and other compounds |
06/19/2008 | US20080146836 New Aminopropylphosphinic acids |
06/19/2008 | US20080146821 Internal 1,15-Lactones Of Fluprostenol And Related Prostaglandin F2a Analogs And Their Use In The Treatment Of Glaucoma And Intraocular Hypertension |
06/19/2008 | US20080146818 Dipeptidylpeptidase IV (DPP-IV) inhibitory activity; (2S,4S)-1-[[N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)); diabetes |
06/19/2008 | US20080146785 Antibody against tumor specific antigen as target |
06/19/2008 | US20080146678 O/W Emulsion Composition |
06/19/2008 | US20080146661 Substituted arylamino -1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-1H-indenes as potassium channel modulators |
06/19/2008 | US20080146660 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
06/19/2008 | US20080146647 Acetylene derivatives having mglur 5 antagonistic activity |
06/19/2008 | US20080146639 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
06/19/2008 | US20080146633 Compositions for skin lightening and toning down pigment disorders, comprising creatinine and/or creatinine derivatives as active substances |
06/19/2008 | US20080146631 Peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis |
06/19/2008 | US20080146628 Lowering prolactin serum level; attention deficit hyperactivity disorder (ADHD) |
06/19/2008 | US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
06/19/2008 | US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof |
06/19/2008 | US20080146592 Method of Treating Preeclampsia Employing Metolazone |
06/19/2008 | US20080146578 Indolylmaleimide derivatives |
06/19/2008 | US20080146572 N-sulfonylurea apoptosis promoters |
06/19/2008 | US20080146568 Spiro-piperidine derivatives |
06/19/2008 | US20080146546 Bicyclic and Tricyclic Heteroaromatic Compounds |
06/19/2008 | US20080146530 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
06/19/2008 | US20080146528 stilbene phosphate derivatives; anticarcinogenic agents; bactericide, fungicide; veterinary medicine |
06/19/2008 | US20080146522 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules |
06/19/2008 | US20080146519 IL-14alpha RNA inhibitors and antibodies to IL-14alpha for treatment of autoimmune diseases and lymphomas |
06/19/2008 | US20080146518 Cationic Lipids for the Transfection of Nucleic Acids |
06/19/2008 | US20080146511 method of peptides, peptides, method and kit for the identification of infections by Mycobacterium leprae, as well as to pharmaceutical and immunological compositions containing as active principle(s), peptide(s) of Mycobacterium leprae or sequences functionally similar |
06/19/2008 | US20080146510 For suppressing cell proliferation/tumor growth or modulating immune system by transformation of T-lymphocytes or enhancement of natural killer cells |
06/19/2008 | US20080146508 Soluble cyclic analogues of beta amyloid peptide |
06/19/2008 | US20080146506 Methods of Suppressing Microglial Activation |
06/19/2008 | US20080146505 47 Human Secreted Proteins |
06/19/2008 | US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins |